Figure 1. HELQ promotes fork slowdown (fork reversal) after treatment with a crosslinking agent (IMAGE)
Caption
A representative figure showing that HELQ-deficient cells fail to undergo normal fork slowing after MMC (a crosslinking agent) treatment, consistent with defective fork reversal.
Credit
Institute for Basic Science
Usage Restrictions
Attribution Required
License
Original content